Literature DB >> 15254914

Presenilin 1 is essential for cardiac morphogenesis.

Mitsunari Nakajima1, Eiko Moriizumi, Haruhiko Koseki, Takuji Shirasawa.   

Abstract

Presenilin 1 (PS1) is the gene responsible for the development of early-onset familial Alzheimer's disease. PS1-deficient mice have been reported to show defects in neurogenesis, somitogenesis and angiogenesis. Here, we report cardiac anomaly in PS1-deficient mice: the mutant hearts exhibited ventricular septal defect, double outlet right ventricle, and stenosis in the pulmonary artery. Immunohistochemistry using anti-PS1 antibody revealed the prominent expression of PS1 in mesenchymal cells at the septal area of the wild-type heart. These results suggest that PS1 may play an essential role in heart development. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254914     DOI: 10.1002/dvdy.20098

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  17 in total

1.  Restricted growth and insulin-like growth factor-1 deficiency in mice lacking presenilin-1 in the neural crest cell lineage.

Authors:  Mitsunari Nakajima; Sono Watanabe; Satoshi Okuyama; Jie Shen; Yoshiko Furukawa
Journal:  Int J Dev Neurosci       Date:  2009-08-07       Impact factor: 2.457

2.  Hydrocephalus and abnormal subcommissural organ in mice lacking presenilin-1 in Wnt1 cell lineages.

Authors:  Mitsunari Nakajima; Keiko Matsuda; Naho Miyauchi; Yasuyoshi Fukunaga; Sono Watanabe; Satoshi Okuyama; Juan Pérez; Pedro Fernández-Llebrez; Jie Shen; Yoshiko Furukawa
Journal:  Brain Res       Date:  2011-01-22       Impact factor: 3.252

Review 3.  Proteostasis in cardiac health and disease.

Authors:  Robert H Henning; Bianca J J M Brundel
Journal:  Nat Rev Cardiol       Date:  2017-06-29       Impact factor: 32.419

Review 4.  Cardiac outflow tract anomalies.

Authors:  Zachary Neeb; Jacquelyn D Lajiness; Esther Bolanis; Simon J Conway
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2013-02-19       Impact factor: 5.814

5.  Mutations of presenilin genes in dilated cardiomyopathy and heart failure.

Authors:  Duanxiang Li; Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Julie Partain; Randal R Nixon; Charles N Allen; Robert P Irwin; Petra M Jakobs; Michael Litt; Ray E Hershberger
Journal:  Am J Hum Genet       Date:  2006-10-24       Impact factor: 11.025

6.  Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy.

Authors:  Davide Gianni; Airong Li; Giuseppina Tesco; Kenneth M McKay; John Moore; Kunal Raygor; Marcello Rota; Judith K Gwathmey; G William Dec; Thomas Aretz; Annarosa Leri; Marc J Semigran; Piero Anversa; Thomas E Macgillivray; Rudolph E Tanzi; Federica del Monte
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

7.  Changes in the expression of the Alzheimer’s disease-associated presenilin gene in drosophila heart leads to cardiac dysfunction.

Authors:  A Li; C Zhou; J Moore; P Zhang; T H Tsai; H C Lee; D M Romano; M L McKee; D A Schoenfeld; M J Serra; K Raygor; H F Cantiello; J G Fujimoto; R E Tanzi
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

Review 8.  Control of intracellular calcium signaling as a neuroprotective strategy.

Authors:  R Scott Duncan; Daryl L Goad; Michael A Grillo; Simon Kaja; Andrew J Payne; Peter Koulen
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

Review 9.  Partitioning the heart: mechanisms of cardiac septation and valve development.

Authors:  Chien-Jung Lin; Chieh-Yu Lin; Chen-Hao Chen; Bin Zhou; Ching-Pin Chang
Journal:  Development       Date:  2012-09       Impact factor: 6.868

10.  Cortical development in the presenilin-1 null mutant mouse fails after splitting of the preplate and is not due to a failure of reelin-dependent signaling.

Authors:  Rita De Gasperi; Miguel A Gama Sosa; Paul H Wen; Jingjun Li; Gissel M Perez; Tom Curran; Gregory A Elder
Journal:  Dev Dyn       Date:  2008-09       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.